Results of adjustable intragastric balloon use according to Body Mass Index values

Aim: In our study, it was aimed to compare the results of adjustable intragastric balloons in patients according to body mass index. Material and Method: We recorded the data of 82 patients that we performed AIGB procedure in the last four years. During the initial implantation of the balloon, inflating was performed with 300-350 cc saline and methylene blue. Body mass index values and excess weight loss ratios of the patients at the time of the balloon removal were noted. Patients' complaints and complications arising after balloon application or additional inflation were reported. Results: It was determined that there was a statistically significant decrease between weight, BMI, and EWL values measured at the 4th, 8th, and 12th months after the first application was performed (p 0.05) in morbidly obese patients (BMI≥40), all other differences were statistically significant (p<0.001). Conclusion: AIGB treatment has satisfactory results in morbidly obese patients. In morbidly obese patients. AIGB may be preferred as an alternative non-surgical method that can be used for weight loss in cases where surgery may carry risk due to co-morbidities or when patients do not prefer surgery.